Kevin L Billups

Title: Kevin L Billups: Innovator in Ischemia Treatment

Introduction

Kevin L Billups is a notable inventor based in Savage, MN (US). He has made significant contributions to the field of medical treatments, particularly in the area of ischemia. His innovative approach involves the use of polypeptides with fibronectin activity, showcasing his dedication to advancing healthcare solutions.

Latest Patents

Kevin L Billups holds 1 patent for a method aimed at treating ischemia using polypeptides with fibronectin-related activity. This patent outlines methods that involve administering an effective amount of one or more polypeptides, which include an amino acid sequence corresponding substantially to an isolated amino acid sequence from the 33 kD carboxy terminal heparin-binding region located on the A chain of fibronectin. Additionally, it covers an RGD-containing amino acid sequence within the 11.5 kD RGDS-mediated cell adhesion region found on all isoforms of fibronectin.

Career Highlights

Throughout his career, Kevin has focused on developing innovative medical treatments that address critical health issues. His work has the potential to improve patient outcomes and enhance the quality of life for those suffering from ischemia.

Collaborations

Kevin has collaborated with esteemed colleagues, including Leo T Furcht and James B McCarthy. These partnerships have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Kevin L Billups is a dedicated inventor whose work in treating ischemia through innovative polypeptide methods demonstrates his commitment to improving healthcare. His contributions to the field are noteworthy and reflect the importance of innovation in medical science.